Globus Medical Shares Surge on Price Target Hike

Globus Medical shares surged by 2.6% today, following RBC Capitals price target increase from $92 to $100, and positive clinical trial results. This move, though not excessive for the typically low-volatility stock, signals investor confidence. The broader market also rallied, with a higher likelihood of interest rate cuts, easing concerns about high stock valuations. Globus Medicals shares are up 6.5% this year, nearing its 52-week high, and a $1000 investment five years ago would now be worth $1333.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.